Scott B. Ullem - 16 Feb 2025 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Chief Financial Officer
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 16 Feb 2025
Transactions value $: -$13,257
Form type: 4
Filing time: 18 Feb 2025, 18:18:44 UTC
Previous filing: 13 Feb 2025
Next filing: 28 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Tax liability	-$13.3K	-174	-0.57%	$76.19	30.4K	16 Feb 2025	Direct
holding	EW	Common Stock						266K	16 Feb 2025	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.